Alyeska Investment Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-595,553	Closed	-$13.7M	–	944
2020 Q4	$13.7M	Buy	+595,553	New	+$13.7M	0.19%	156